Literature DB >> 17335927

Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages.

Keiji Hirota1, Taizo Hasegawa, Hideyuki Hinata, Fuminori Ito, Hiroyuki Inagawa, Chie Kochi, Gen-Ichiro Soma, Kimiko Makino, Hiroshi Terada.   

Abstract

We examined the phagocytic activities of alveolar macrophages (NR8383 cells) toward poly(lactic-co-glycolic) acid (PLGA) microspheres (MS) loaded with the anti-tuberculosis agent rifampicin (RFP), the sizes of which were between 1 microm and 10 microm. We found that 1) the phagocytosis was dependent greatly on the particle size and the number of particles added; 2) macrophages phagocytosed considerably the PLGA microspheres loaded with RFP, the diameter of which was between 1 microm and 6 microm, but took up few 10-microm particles; 3) the population of the macrophages that phagocytosed 1-microm or 3-microm particles was larger than that of those phagocytosed 6- or 10-microm particles; 4) a considerable population of macrophages were not able to phagocytose even the 1- and 3-microm particles; 5) the most efficient deliveries of RFP into each macrophage cell and a large population of macrophages were achieved by the phagocytosis of 3-microm particles; and 6) phagocytosis did not affect macrophage viability in 4 h after the start of phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17335927     DOI: 10.1016/j.jconrel.2007.01.013

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  29 in total

1.  Macrophage-specific targeting of isoniazid through mannosylated gelatin microspheres.

Authors:  Sanjay Tiwari; Adya P Chaturvedi; Yamini B Tripathi; Brahmeshwar Mishra
Journal:  AAPS PharmSciTech       Date:  2011-07-06       Impact factor: 3.246

2.  Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.

Authors:  Xu Song; Qing Lin; Ling Guo; Yao Fu; Jianfeng Han; Huan Ke; Xun Sun; Tao Gong; Zhirong Zhang
Journal:  Pharm Res       Date:  2014-11-19       Impact factor: 4.200

Review 3.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

4.  Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge.

Authors:  Ky V Hoang; Heather Curry; Michael A Collier; Hassan Borteh; Eric M Bachelder; Larry S Schlesinger; John S Gunn; Kristy M Ainslie
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

5.  PLGA microparticles in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen TB10.4-Ag85B.

Authors:  Shuai Shi; Anthony J Hickey
Journal:  Pharm Res       Date:  2009-12-19       Impact factor: 4.200

6.  In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants.

Authors:  Eric M Bachelder; Tristan T Beaudette; Kyle E Broaders; Jean M J Fréchet; Mark T Albrecht; Alfred J Mateczun; Kristy M Ainslie; John T Pesce; Andrea M Keane-Myers
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

7.  Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection.

Authors:  Ky V Hoang; Hassan M Borteh; Murugesan V S Rajaram; Kevin J Peine; Heather Curry; Michael A Collier; Michael L Homsy; Eric M Bachelder; John S Gunn; Larry S Schlesinger; Kristy M Ainslie
Journal:  Int J Pharm       Date:  2014-10-22       Impact factor: 5.875

8.  Application of a four-fluid nozzle spray drier to prepare inhalable rifampicin-containing mannitol microparticles.

Authors:  Takuto Mizoe; Tetsuya Ozeki; Hiroaki Okada
Journal:  AAPS PharmSciTech       Date:  2008-06-18       Impact factor: 3.246

9.  Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by bacillus anthracis.

Authors:  Kevin L Schully; Sadhana Sharma; Kevin J Peine; John Pesce; Margret A Elberson; Mariko E Fonseca; Angela M Prouty; Matthew G Bell; Hassan Borteh; Matthew Gallovic; Eric M Bachelder; Andrea Keane-Myers; Kristy M Ainslie
Journal:  Pharm Res       Date:  2013-01-25       Impact factor: 4.200

10.  Stimulation of phagocytic activity of alveolar macrophages toward artificial microspheres by infection with mycobacteria.

Authors:  Keiji Hirota; Keishiro Tomoda; Hiroyuki Inagawa; Chie Kohchi; Gen-Ichiro Soma; Kimiko Makino; Hiroshi Terada
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.